Kanaly Trust’s Pfizer PFE Stock Holding History

Kanaly Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$183K	Sell	5,936 -1,164	-16%	-$35.5K	0.04%	151
2016 Q3	$228K	Sell	7,100 -943	-12%	-$31.5K	0.05%	141
2016 Q2	$269K	Buy	8,043 +866	+12%	+$27.6K	0.05%	125
2016 Q1	$202K	Sell	7,177 -487	-6%	-$13.9K	0.04%	147
2015 Q4	$235K	Sell	7,664 -265	-3%	-$8.34K	0.05%	134
2015 Q3	$236K	Buy	7,929 +43	+0.5%	+$1.38K	0.05%	130
2015 Q2	$251K	Sell	7,886 -5,271	-40%	-$172K	0.05%	142
2015 Q1	$434K	Sell	13,157 -314	-2%	-$9.98K	0.08%	116
2014 Q4	$398K	Buy	13,471 +1,012	+8%	+$29K	0.08%	130
2014 Q3	$350K	Sell	12,459 -13,806	-53%	-$387K	0.07%	147
2014 Q2	$740K	Sell	26,265 -119	-0.5%	-$3.39K	0.13%	88
2014 Q1	$804K	Buy	26,384 +860	+3%	+$25.6K	0.16%	83
2013 Q4	$742K	Buy	+25,524	New	+$743K	0.15%	81
2013 Q3	–	Sell	-7,785	Closed	-$206K	–	98
2013 Q2	$206K	Buy	+7,785	New	+$215K	0.06%	82

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Kanaly Trust's PFE Position: Q4 2016 in Review

Kanaly Trust reduced its Pfizer (PFE) stake by 16% in Q4 2016, selling an estimated $35.5K and leaving 5,936 shares worth $183K. The position accounts for 0.04% of the portfolio, ranked #151.

Kanaly Trust first reported a position in PFE in Q2 2013 and has held it in 14 quarters since. The position peaked at $804K in Q1 2014. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

Kanaly Trust held 5,936 shares of Pfizer worth $183K as of Q4 2016.
Kanaly Trust sold 1,164 Pfizer shares in Q4 2016, an estimated $35.5K.
Pfizer made up 0.04% of Kanaly Trust's portfolio in Q4 2016, its #151 holding.
Kanaly Trust first reported a position in Pfizer in Q2 2013 and has held it in 14 quarters since.
Kanaly Trust's Pfizer position peaked at $804K in Q1 2014.
2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.